There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (1)

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.


Actions Overview (1)

Date Actions Overview
07/31/2018Introduced in House

All Actions (3)

Date All Actions
08/03/2018Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
07/31/2018Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
07/31/2018Introduced in House
Action By: House of Representatives

Cosponsors (0)

No cosponsors.


Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce07/31/2018 Referred to
House Energy and Commerce Subcommittee on Health08/03/2018 Referred to

No related bill information was received for H.R.6642.


Subjects (4)


Latest Summary (1)

There is one summary for H.R.6642. View summaries

Shown Here:
Introduced in House (07/31/2018)

This bill terminates certain limitations regarding drug rebates under Medicaid. Currently, the maximum rebate that drug manufacturers must pay under Medicaid for single-source and innovator multiple-source drugs is 100% of the average manufacturer price of the drug. The bill specifies that this limitation only applies to rebate periods that begin before January 1, 2019.